The UAE Ministry of Health and Prevention (MOHAP) has actually provided a public warning against the circulation of video clips including healthcare details, particularly with relationship to medicines The warning was provided complying with the current blood circulations of a video clip regarding the antibiotic Flumox (250 and 500 grams) generated by Egyptian International Pharmaceutical Industries Company (EIPICO). This video is dated in 2015 and it must not be flowed now as it causes panic among the public and provides wrong impacts regarding the medicine control system, it additionally impacts the track record of the exporting nation and the generating company, which is in fact among the best in Egypt.

According to H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Policy and Licensing, MOHAP, and Chairman of the Supreme Pharmacovigilance Committee, the antibiotic Flumox is not signed up in the UAE. He added that the Egyptian authorities has actually taken 6 million capsules of the banned drug in 2015.

7 initiatives to lower the costs of drugs led to the arrangement of fairly priced medicines.

H.E. Dr. Al Amiri claimed that the Ministry has applied seven campaigns to decrease the rates of medications in coordination with international suppliers, ensuring simple accessibility to top quality, secure and efficient medicines. He described the Ministry's initiatives to motivate global pharmaceutical business to manufacture medications in the nation in collaboration with local factories as a start to lowering the price of delivery which could dramatically contribute in lowering medicine rates.

The Assistant Undersecretary mentioned that the transfer of medication production modern technology to local factories will certainly result in the production of innovative and similar medicines within the UAE, offering people with accessibility to excellent quality medications at reasonable costs. He clarified that the nation is working to develop this vital sector and assistance medicine safety through the production of regulations and plans, and global marketing contracts to accelerate the procedure of importation of raw materials in addition to the promotion of medical research to make it possible for the local pharmaceutical market to accomplish self-sufficiency.

MOHAP's strategies to curb the practice of scams and contraband of medicines

Medicinal fraud is a significant and disturbing method for regional medical care authorities, who are collaborating with each other to set out procedures and control procedures to restrict the spread of this illegal practice in alignment with the global health procedures that assure quality.

The role of the UAE Ministry of Health, in collaboration with the other health authorities with the National Anti-Counterfeit Committee, is to attract a strategy for drug control, specifically since the pharmaceutical market is witnessing vibrant growth with numerous new products. The obstacle allows since medicine is a tactical commodity unique from various other durable goods. Their importance is not subject to supply and demand yet it is an immediate have to save human life. And the ministry's supreme goal is to guarantee that all clients have accessibility to risk-free, effective and affordable medicine.

MOHAP urges public to report unlawful trading and use Flumox

MOHAP likewise advised the general public to avoid interacting any kind of healthcare information that is not confirmed by the ministry or by the local health authorities and to report any kind of information about the prohibited trade and use Flumox in the UAE using the toll toll free number 80011111, visit TAMINI Link on the Ministry's website, or conatct any kind of health authority in the UAE.

MOHAP maintains regular coordination and communication with global drug agencies

H.E. Dr. Al Amiri explained that the Ministry with local health authorities and the National Anti-Counterfeit committee keeps continuous interaction and sychronisation with local health authorities and global medication firms to check out any kind of warnings, grievances and negative effects reported on any type of drug class globally.